Toronto General Hospital

RSNA: Researchers Look at Environmental Impacts of AI Tools

Retrieved on: 
Tuesday, February 27, 2024
Acquisition, Algorithm, Artificial intelligence, AI, Research, Education, Toronto General Hospital, Radiation, RSNA, Hospital, M.A, Travel, Society, University, Medical imaging, Health, GHG, OAK, Sustainability, Medical device

OAK BROOK, Ill., Feb. 27, 2024 /PRNewswire-PRWeb/ -- As artificial intelligence (AI) is increasingly used in radiology, researchers caution that it's essential to consider the environmental impact of AI tools, according to a focus article published today in Radiology, a journal of the Radiological Society of North America (RSNA).

Key Points: 
  • "The development and deployment of AI models consume large amounts of energy, and the data storage needs in medical imaging and AI are growing exponentially."
  • Dr. Hanneman and a team of researchers looked at the benefits and downsides of incorporating AI tools into radiology.
  • However, the energy required to develop AI tools and store the associated data significantly contributes to GHG.
  • To decrease GHG emissions from data storage and the AI model development process, the researchers also offered other suggestions.

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

Retrieved on: 
Thursday, February 1, 2024
Science, Other Science, Research, Natural Resources, Pharmaceutical, Alternative Medicine, Health, Cannabis, Knowledge, School, Chronic pain, Hospital, Faculty, Patient, FRCPC, Public health, Toronto General Hospital, Advisory Committee, Knowledge translation, Medical school, Entrepreneurship, Queen Elizabeth, Consortium, Assistant, Pain management, Drug development, Risk, Anesthesiology, Toronto Centre, Doctor of Philosophy, University, Committee, Medicine, Pharmaceutical industry

ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, today announced the appointment of Hance Clarke, MD, PhD, FRCPC to ZYUS Life Sciences Inc.’s Clinical Advisory Committee.

Key Points: 
  • ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, today announced the appointment of Hance Clarke, MD, PhD, FRCPC to ZYUS Life Sciences Inc.’s Clinical Advisory Committee.
  • Dr. Clarke is internationally recognized for his outstanding contributions to research productivity and advancements in patient care.
  • "We are pleased to announce the appointment of Dr. Hance Clarke to the Clinical Advisory Committee," said Brent Zettl, President and CEO of the Company.
  • This strategic addition to our Clinical Advisory Committee reaffirms ZYUS’ commitment to advancing non-opioid-based therapies as a viable alternative for managing pain.”
    "I am honored to join ZYUS’ Clinical Advisory Committee and eager to contribute to ZYUS’ important work.

UHN SHOWS WHY IT'S CANADA'S #1 HOSPITAL IN VERY FIRST BRAND CAMPAIGN

Retrieved on: 
Monday, January 22, 2024
Patient, Research, Hospital, Health, Partnership, History, Heart failure, Medicine, Parkinson's disease, College, Toronto General Hospital, Education, Smartphone, Pharmaceutical industry

Launching today, the UHNITED campaign focuses on the teams working together across UHN to challenge the status quo of healthcare.

Key Points: 
  • Launching today, the UHNITED campaign focuses on the teams working together across UHN to challenge the status quo of healthcare.
  • "UHN is the top hospital in the country and the #1 publicly funded hospital in the world.
  • Zulu Alpha Kilo – one of the top creative agencies in the country – developed the campaign alongside UHN and UHN Foundation.
  • The UHNITED campaign features paid advertising that will run across digital, print and out-of-home channels, along with digital content.

Octapharma USA Presents Factor Concentrates for Perioperative Bleeding Symposium for ASA Annual Meeting Attendees

Retrieved on: 
Tuesday, October 10, 2023
Annual general meeting, Thrombophilia, Algorithm, American Society of Anesthesiologists, Disease, Food, VKA, Bleeding, PST, MD, Society, Mortality, Factor, Hospital, FDA, Food and Drug Administration, Warfarin, Toronto General Hospital, PCC, FC, Octapharma, Duke University, Hemostasis, The Reconstruction (1970 film), ASA, Moscone Center, Toronto, Patient, Nightclub, Dentistry, Pharmaceutical industry, Fibrinogen, Research

PARAMUS, N.J., Oct. 10, 2023 /PRNewswire/ -- Octapharma USA will sponsor the scientific symposium, Factor Concentrates for Perioperative Bleeding – Global Perspectives, Sunday, October 15th in conjunction with the American Society of Anesthesiologists (ASA) Annual Meeting in San Francisco.

Key Points: 
  • PARAMUS, N.J., Oct. 10, 2023 /PRNewswire/ -- Octapharma USA will sponsor the scientific symposium, Factor Concentrates for Perioperative Bleeding – Global Perspectives, Sunday, October 15th in conjunction with the American Society of Anesthesiologists (ASA) Annual Meeting in San Francisco.
  • The symposium will address current gaps in research related to factor concentrates, including prothrombin complex concentrates (PCC) and fibrinogen concentrates (FC), for perioperative bleeding management.
  • Kamrouz Ghadimi, MD, MHSc, Department of Anesthesiology, Duke University, will discuss, "Perioperative Coagulopathic Bleeding – Definition, Treatment Algorithms, and POC Testing, Oh My!"
  • The role of factor concentrates and blood products for management of bleeding in surgery;
    The latest research and current practice guidelines for factor concentrates in perioperative bleeding; and
    Individualized bleeding management strategies in cardiac surgery, with patient case presentations.

Sequana Medical announces additional data on safety, quality of life and survival from North American pivotal alfapump® study (POSEIDON)

Retrieved on: 
Wednesday, June 21, 2023
Overload, Infection, EASL, University, Paracentesis, Heart failure, Prevalence, NASH, Liver disease, Survival, Cancer, Quality of life, Kidney, Ascites, AKI, Congress, Acute kidney injury, Literature, HIV disease progression rates, Toronto General Hospital, Patient, University of Toronto, Brussels Stock Exchange, Fatty liver disease, Maes, Creatine, Hospital, Principal, Cirrhosis, Alcoholic liver disease, Death, Meldi Mata, Safety, Pharmaceutical industry, Medical device, Medical imaging, Hepatology

Together with the positive primary endpoint data reported previously, these results further support the clinical benefits of the alfapump and show a survival rate that compares favorably to literature.

Key Points: 
  • Together with the positive primary endpoint data reported previously, these results further support the clinical benefits of the alfapump and show a survival rate that compares favorably to literature.
  • Renal function is often impaired in patients with advanced cirrhosis and patients with evidence of renal failure were excluded from the study.
  • Sequana Medical management will host a conference call with a live webcast presentation today at 15:00 CEST / 09:00 am EST.
  • The webcast and conference call will be conducted in English and a replay will be available on Sequana Medical’s website shortly after.

2023 BILD Awards celebrate home building excellence in the GTA

Retrieved on: 
Friday, May 12, 2023
Tridel, Clockwork, Organic, Interview, NEXT Woman of the Year awards, Life, Sunnybrook Health Sciences Centre, Marketing, Professional, Hospice, The Heights, GTA, Human, Green Builder Media, Canadian Home Builders' Association, Organization, Mackenzie Health, Mattamy Homes, TACC, Toronto General Hospital, Construction, Pinnacle, Greater Toronto Area, Architecture, Hospital, Southlake Regional Health Centre, Markham Stouffville Hospital, Auction, Property management, Film industry, Palacio del Marqués de las Claras, BILD, Lakeview Village Historic District

Toronto, ON, May 12, 2023 (GLOBE NEWSWIRE) -- The Building Industry and Land Development Association (BILD) recognized excellence in the design, construction, marketing and sales of new homes in the GTA at its 2023 BILD Awards, held on May 11.

Key Points: 
  • Toronto, ON, May 12, 2023 (GLOBE NEWSWIRE) -- The Building Industry and Land Development Association (BILD) recognized excellence in the design, construction, marketing and sales of new homes in the GTA at its 2023 BILD Awards, held on May 11.
  • BILD presented 47 awards in the categories of architecture, design, marketing, people and sales, and in the prestigious Pinnacle category.
  • “The BILD Awards finalists and winners exemplify excellence and innovation as they bring the GTA’s new communities to life,” said Dave Wilkes, BILD President & CEO.
  • “The BILD Awards are an opportunity to celebrate these dynamic companies and remarkable people shaping our region.”
    Silvio De Gasperis, President & CEO of the TACC Group of Companies, received BILD’s Lifetime Achievement Award.

Ontario Health Coalitions announce first 500 voting stations in the people’s referendum

Retrieved on: 
Wednesday, May 3, 2023
Coalition, Volunteering, Learning Disability Coalition, Hospital, Disability, Privatization, University Avenue, Toronto General Hospital, Nursing

What: The Ontario & Toronto Health Coalitions will be holding a press conference tomorrow to announce the first 500 voting stations in the people’s referendum on the privatization of our public hospitals.

Key Points: 
  • What: The Ontario & Toronto Health Coalitions will be holding a press conference tomorrow to announce the first 500 voting stations in the people’s referendum on the privatization of our public hospitals.
  • All press conferences will be visual with leaflets, ballots, ballot boxes, maps of voting stations, ribbons and volunteers, including those on Zoom.
  • In each press conference, a large group of volunteers will announce the first 500 voting stations organized in the community-led referendum.
  • The following local coalitions in additional communities will also be announcements tomorrow, with local coalitions in additional communities will be making announcements in the coming days:

Ontario Health Coalitions announce first 500 voting stations in citizen-led referendum

Retrieved on: 
Tuesday, May 2, 2023
Coalition, Volunteering, Hospital, Privatization, University Avenue, Toronto General Hospital, Management

TORONTO, May 02, 2023 (GLOBE NEWSWIRE) -- All press conferences will be visual with leaflets, ballots, ballot boxes, maps of voting stations, ribbons and volunteers, including those on Zoom.

Key Points: 
  • TORONTO, May 02, 2023 (GLOBE NEWSWIRE) -- All press conferences will be visual with leaflets, ballots, ballot boxes, maps of voting stations, ribbons and volunteers, including those on Zoom.
  • In each press conference a large group of volunteers will announce the first 500 voting stations organized in the community-led referendum.
  • The Coalition will announce the next steps in this unprecedented effort to stop the privatization of Ontario’s public hospital services.
  • Outside Toronto General Hospital, on University Avenue, just south of College St, Toronto, ON
    Natalie Mehra, Ontario Health Coalition Executive Director, 416-230-6402, [email protected]

Sky View Suites & StayWell Announce Long-Term Partnership

Retrieved on: 
Tuesday, December 20, 2022
Hospital, Heart failure, Patient, Family, CTEPH, Partnership, Growth, Chronic thromboembolic pulmonary hypertension, Toronto General Hospital, Caregiver, Artery, Health insurance, Communications satellite

StayWell and Sky View Suites are proud to announce a long-term partnership that is expected to support patient accommodations across Canada.

Key Points: 
  • StayWell and Sky View Suites are proud to announce a long-term partnership that is expected to support patient accommodations across Canada.
  • The partnership leverages the respective strengths of StayWell and Sky View Suites to help expand access and improve service to patients relocating for medical treatment.
  • StayWell and Sky View Suites announce a five-year partnership that to support patient accommodations across Canada.
  • – Sass Khazzam – StayWell CEO
    Together, StayWell and Sky View Suites have changed the lives of many, and saved the lives of some.

Sobi Receives Approval from Health Canada for Empaveli™ (pegcetacoplan) for the Treatment of Certain Patients with Paroxysmal Nocturnal Hemoglobinuria

Retrieved on: 
Friday, December 9, 2022
Eculizumab, Thrombosis, Neurology, Breathe Me, Quality of life, Incidence, Toronto General Hospital, Blood, Hospital, Fatigue, Safety, Erectile dysfunction, McKinley, The New England Journal of Medicine, Swedish Orphan Biovitrum, PEGASUS, Nephrology, Pain, PNH, Geographic atrophy, Paroxysmal nocturnal hemoglobinuria, SEK, Hemolysis, The Amazing Race Canada 4, Degenerative disease, United Arab Emirates, Hematology, Nasdaq Stockholm, Anemia, Health Canada, Pharmaceutical industry, Sales, Patient, Pegcetacoplan, EU

PNH is characterized by the destruction of red blood cells (hemolysis) and release of free hemoglobin that can cause thrombosis and require frequent transfusions.

Key Points: 
  • PNH is characterized by the destruction of red blood cells (hemolysis) and release of free hemoglobin that can cause thrombosis and require frequent transfusions.
  • Empaveli is approved in the United States and the United Arab Emirates for the treatment of adults with PNH.
  • In Australia, Empaveli is approved for the treatment of adult patients with PNH who have an inadequate response to, or are intolerant of, a C5 inhibitor.
  • McKinley C. Extravascular Hemolysis Due to C3-Loading in Patients with PNH Treated with Eculizumab: Defining the Clinical Syndrome.